Impaired 11-β Hydroxysteroid Dehydrogenase Type 2 Activity in Sweat Gland Ducts in Human Essential Hypertension-Reference-Cited by-同舟云学术

Impaired 11-β Hydroxysteroid Dehydrogenase Type 2 Activity in Sweat Gland Ducts in Human Essential Hypertension

Published:2004-04 Issue:4 Volume:43 Page:803-808
ISSN:0194-911X
Container-title:Hypertension
language:en
Short-container-title:Hypertension

Author:

Bocchi Brigitte¹,Kenouch Sabine¹,Lamarre-Cliche Maxime¹,Muffat-Joly Martine¹,Capron Michel Hubert¹,Fiet Jean¹,Morineau Gilles¹,Azizi Michel¹,Bonvalet Jean Pierre¹,Farman Nicolette¹

Affiliation:

1. From INSERM U 478 (B.B., S.K., J.P.B., N.F.) and IFR 02 (M.M.-J.), Faculté de Médecine X, Bichat, Université Paris 7; Centre d’Investigation Clinique 9201 AP-HP/Inserm (M.L.-C., M.A.), Hôpital Européen Georges Pompidou; Fondation Searle France (M.H.C.); and Laboratoire de Biologie Hormonale (J.F., G.M.), Hôpital Saint Louis, Paris, France.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Internal Medicine

Reference40 articles.

1. Multiple aspects of mineralocorticoid selectivity

2. Mineralocorticoid Action: Target Tissue Specificity Is Enzyme, Not Receptor, Mediated

3. LOCALISATION OF 11β-HYDROXYSTEROID DEHYDROGENASE—TISSUE SPECIFIC PROTECTOR OF THE MINERALOCORTICOID RECEPTOR

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tissue Glucocorticoid Metabolism in Adrenal Insufficiency: A Prospective Study of Dual-release Hydrocortisone Therapy;The Journal of Clinical Endocrinology & Metabolism;2023-06-20

2. 11β-hydroxysteroid dehydrogenases: A growing multi-tasking family;Molecular and Cellular Endocrinology;2021-04

3. Aldosterone sensitivity: an opportunity to explore the pathogenesis of hypertension;American Journal of Physiology-Renal Physiology;2021-03-01

4. New Insights on the Role of Sodium in the Physiological Regulation of Blood Pressure and Development of Hypertension;Frontiers in Cardiovascular Medicine;2019-09-16

5. Impaired 11β-Hydroxysteroid Dehydrogenase Type 2 in Glucocorticoid-Resistant Patients;The Journal of Clinical Endocrinology & Metabolism;2019-06-21